Dianon Systems develops prostate specific antigen (PSA) II test
This article was originally published in Clinica
Executive Summary
Dianon Systems (US) and researchers at the John Hopkins University Medical Center, Maryland, have developed a second- generation prostate specific antigen (PSA) test called PSA II. Presented at the American Urological Association in Orlando, the test may be useful in discriminating between prostate cancer and benign prostatic hyperplasia (BPH), up to seven years before current tests can detect prostate cancer.